ask="12.50"
ask_size="100"
average_daily_volume="30275"
bid="N/A"
bid_size="N/A"
book_value="3.34"
change="-0.30"
change_from_200_day_moving_average="4.77"
change_from_50_day_moving_average="2.42"
change_from_52_week_high="-1.05"
change_From_52_week_low="8.18"
change_in_percent="-2.50%"
close="11.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.53"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="12.00"
high_52_weeks="12.75"
last_trade_date="3/6/2017"
last_trade_price="11.70"
last_trade_size="100"
last_trade_time="3:59pm"
low="11.41"
low_52_weeks="3.52"
market_capitalization="248.98M"
moving_average_200_day="6.93"
moving_average_50_day="9.28"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.81"
open="12.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+68.88%"
percent_change_from_50_day_moving_average="+26.02%"
percent_change_from_52_week_high="-8.24%"
percent_change_from_52_week_low="+232.39%"
previous_close="12.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.59"
price_per_sales="49.11"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.35"
stock_exchange="NMS"
symbol="NBRV"
volume="25515"
weeks_range_52="3.52 - 12.75"
